Mergers and acquisitions (M&A) are always exciting news. But the temperature has really been dialed up on the upcoming mega-merger between two big Canadian cannabis players, Aphria (NASDAQ:APHA)and Tilray (NASDAQ:TLRY). Since marijuana sales have skyrocketed amid the pandemic, the sector is the talk of the town. The expectation surrounding the new entity captured investors' attention even more, elevating the stock prices of both Aphria and Tilray this year. So far in 2021, Tilray's stock has gained 227%, while Aphria has surged 180%. The industry benchmark, the Horizons Marijuana Life Sciences ETF, has gained 63% over the same time frame.

Investors sure did enjoy solid gains from the recent surge, and are expecting even more upside. In my opinion, selling Aphria or Tilray's shares to enjoy short-term returns is not the best option right now. Here's why, if you have the time to wait, holding on for the long haul is the wiser move.

More in category

Median home price in Boston-area hits record of nearly $725K
April 21, 2021FOX Business
Median home price in Boston-area hits record of nearly $725K
Mortgage rates at 2-month lows entice borrowers
April 21, 2021FOX Business
Mortgage rates at 2-month lows entice borrowers
Demand may exceed supply as CEO of one of the world’s biggest hotel groups sees ‘surge’ in bookings
April 21, 2021MarketWatch
Demand may exceed supply as CEO of one of the world’s biggest hotel groups sees ‘surge’ in bookings
Middleby to acquire Welbilt in all-stock deal valued at $4.3 billion
April 21, 2021MarketWatch
Middleby to acquire Welbilt in all-stock deal valued at $4.3 billion
The Fed won’t taper its asset buying till 2023, says former White House economist. Here’s why.
April 21, 2021MarketWatch
The Fed won’t taper its asset buying till 2023, says former White House economist. Here’s why.
European stocks rebound from worst losses in four months, led by chipmaker ASML
April 21, 2021MarketWatch
European stocks rebound from worst losses in four months, led by chipmaker ASML
UiPath IPO: 5 things to know about the ‘software robots’ company valued at nearly $30 billion
April 20, 2021MarketWatch
UiPath IPO: 5 things to know about the ‘software robots’ company valued at nearly $30 billion
Stock-market sentiment shifts after investor euphoria pushed U.S. equities to record highs
April 20, 2021MarketWatch
Stock-market sentiment shifts after investor euphoria pushed U.S. equities to record highs
Opinion: There is a new normal for Netflix, and that is not necessarily a bad thing
April 20, 2021MarketWatch
Opinion: There is a new normal for Netflix, and that is not necessarily a bad thing
Netflix predicts worst quarter for streaming growth in its history, stock falls 9%
April 20, 2021MarketWatch
Netflix predicts worst quarter for streaming growth in its history, stock falls 9%
Overstock CEO says Coinbase, Robinhood are in its crosshairs as it builds out rival crypto trading venue
April 20, 2021MarketWatch
Overstock CEO says Coinbase, Robinhood are in its crosshairs as it builds out rival crypto trading venue
Ted Nugent tests positive for COVID-19: ‘I thought I was dying’
April 20, 2021MarketWatch
Ted Nugent tests positive for COVID-19: ‘I thought I was dying’
Opinion: High-momentum stocks have been losing steam and this could be signaling a market top
April 20, 2021MarketWatch
Opinion: High-momentum stocks have been losing steam and this could be signaling a market top
What is the European Super League, and why are soccer fans so upset about it?
April 19, 2021MarketWatch
What is the European Super League, and why are soccer fans so upset about it?
Your streaming subscriptions reshaped Disney and turbocharged Netflix — now comes making more money off you
April 16, 2021MarketWatch
Your streaming subscriptions reshaped Disney and turbocharged Netflix — now comes making more money off you
3 Cheap Cathie Wood Stocks to Buy Right Now
April 21, 2021The Motley Fool
3 Cheap Cathie Wood Stocks to Buy Right Now
These 3 dividend ETFs are a retiree's best friend
April 21, 2021FOX Business
These 3 dividend ETFs are a retiree's best friend
Netflix Earnings in 6 Must-See Metrics
April 21, 2021The Motley Fool
Netflix Earnings in 6 Must-See Metrics
Why Novavax Could Be the Biggest Winner From Johnson & Johnson's Vaccine Woes
April 21, 2021The Motley Fool
Why Novavax Could Be the Biggest Winner From Johnson & Johnson's Vaccine Woes
Here's the Dr. Fauci Statement That Could Mean Good News for Inovio
April 21, 2021The Motley Fool
Here's the Dr. Fauci Statement That Could Mean Good News for Inovio
3 Stocks for a Better Retirement
April 21, 2021The Motley Fool
3 Stocks for a Better Retirement